Amyris successfully scaled up the commercial production of Cannabigerol

John Melo, President and Ceo of Amyris

Amyris, a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully scaled up the commercial production of Cannabigerol (CBG) leveraging its industrial fermentation process capability.

Continue reading